These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs]. Lange H; Eberhart L Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs]. van den Bemt BJ; Benraad HB; Rasker JJ Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular complications of non-steroidal anti-inflammatory drugs. Fosslien E Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252 [TBL] [Abstract][Full Text] [Related]
8. [Drug safety of NSAIDs and COX-2 inhibitors]. Herdegen T; Fauler J Med Monatsschr Pharm; 2006 Apr; 29(4):122-8. PubMed ID: 16628961 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of low-dose aspirin, traditional non-steroidal anti-inflammatory drugs and coxibs. Patrono C Bull Mem Acad R Med Belg; 2010; 165(1-2):115-23; discussion 124. PubMed ID: 21162342 [No Abstract] [Full Text] [Related]
10. Mayo Clinic office visit. NSAIDs and cardiovascular risks. An interview with Sharon Mulvagh, M.D. Mulvagh S Mayo Clin Womens Healthsource; 2010 Nov; 14(11):6. PubMed ID: 20881928 [No Abstract] [Full Text] [Related]
11. [Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain]. Nurmohamed MT Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1313; author reply 1313-4. PubMed ID: 17624165 [No Abstract] [Full Text] [Related]
13. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Mitchell JA; Warner TD Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347 [TBL] [Abstract][Full Text] [Related]
14. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema? Aneja A; Farkouh ME Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular issues of COX-2 inhibitors and NSAIDs. Wong M; Chowienczyk P; Kirkham B Aust Fam Physician; 2005 Nov; 34(11):945-8. PubMed ID: 16299629 [TBL] [Abstract][Full Text] [Related]
16. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Woodruff T Intern Med J; 2006 Dec; 36(12):797-8; author reply 798-9. PubMed ID: 17096747 [No Abstract] [Full Text] [Related]
17. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs. Joshi GP; Gertler R; Fricker R Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885 [TBL] [Abstract][Full Text] [Related]